| Literature DB >> 24314116 |
Andreas M Neophytou1, Jaime E Hart, Jennifer M Cavallari, Thomas J Smith, Douglas W Dockery, Brent A Coull, Eric Garshick, Francine Laden.
Abstract
BACKGROUND: Experimental evidence suggests that inhaled particles from vehicle exhaust have systemic effects on inflammation, endothelial activation and oxidative stress. In the present study we assess the relationships of short-term exposures with inflammatory endothelial activation and oxidative stress biomarker levels in a population of trucking industry workers.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24314116 PMCID: PMC3882104 DOI: 10.1186/1476-069X-12-105
Source DB: PubMed Journal: Environ Health ISSN: 1476-069X Impact factor: 5.984
Study population baseline characteristics in a sample of male, non-smoking trucking industry workers
| Total no. | 67 | 35 | 14 | 18 |
| Race (no. (%)) | | | | |
| White | 62 (93%) | 32 (91%) | 14 (100%) | 16 (89%) |
| Hispanic | 5 (7%) | 3 (9%) | 0 (0%) | 2 (11%) |
| Age (years, mean ± SD) | 50.4 ± 8.5 | 51.1 ± 7.8 | 47.9 ± 11.0 | 50.8 ± 7.5 |
| BMI (kg/m2, mean ± SD) | 30.4 ± 4.4 | 30.8 ± 4.1 | 29.8 ± 4.3 | 30.1 ± 5.2 |
| Past smoker (no. (%)) | 36 (54%) | 23 (66%) | 6 (43%) | 7 (39%) |
| Exercise (hrs/wk, mean ± SD) | 3.3 ± 3.7 | 2.3 ± 2.9 | 4.6 ± 5.4 | 4.4 ± 2.7 |
| Hypertension (no. (%)) | 24 (36%) | 13 (37%) | 6 (43%) | 5 (28%) |
| Heart disease (no. (%)) | 3 (4%) | 0 (0%) | 1 (7%) | 2 (11%) |
| CHD (no. (%)) | 6 (9%) | 4 (11%) | 1 (7%) | 1 (6%) |
| Diabetes (no. (%)) | 1 (1.5%) | 1 (3%) | 0 (0%) | 0 (0%) |
| Medication use | | | | |
| Blood pressure | 19 (28%) | 9 (26%) | 5 (36%) | 5 (28%) |
| Lipid lowering | 24 (36%) | 14 (40%) | 4 (29%) | 6 (33%) |
| Aspirin | 17 (25%) | 9 (26%) | 2 (14%) | 6 (33%) |
| Total workdays (mean ± SD) | 4.0 ± 0.5 | 3.9 ± 0.4 | 4.4 ± 0.5 | 3.9 ± 0.5 |
| Avg shift duration (hrs, mean ± SD) | 9.5 ± 1.8 | 10.6 ± 1.0 | 8.6 ± 1.6 | 8.1 ± 1.9 |
| Total hrs worked during study period | 45.8 ± 9.4 | 50.7 ± 6.9 | 41.7 ± 9.3 | 39.3 ± 8.8 |
Figure 1Boxplots for first and last-day average exposure levels. PM2.5, EC, OC levels by job title and all job-titles combined. The outer box lines represent the first and third quartiles, while the thick horizontal line in the box represents the median. The “whiskers” extend to the values of the sample within 1.5 IQR of the lower and upper quartiles, and values outside this range are represented as circles.
Figure 2Boxplots for endothelial activation, inflammation, and oxidative stress biomarker levels. Average levels from the four measurement occasions used for each participant, shown for by job title and all job-titles combined.
Mean (± SD) and geometric mean (± GSD) for subject specific mean marker levels averaged over the 4 different measurement points
| ICAM-1 (ng/mL) | 202 ± 40 | 198 ± 1.22 | 208 ± 42 | 203 ± 1.23 | 216 ± 34 | 213 ± 1.17 | 181 ± 32 | 178 ± 1.19 |
| VCAM-1 (ng/mL) | 677 ± 131 | 661 ± 1.21 | 679 ± 144 | 663 ± 1.23 | 673 ± 123 | 658 ± 1.21 | 675 ± 115 | 661 ± 1.19 |
| IL-6 (pg/mL) | 1.38 ± 1.20 | 1.09 ± 1.71 | 1.36 ± 0.79 | 1.12 ± 1.59 | 1.50 ± 2.17 | 0.98 ± 2.14 | 1.30 ± 0.82 | 1.11 ± 1.61 |
| CRP (mg/L) | 1.66 ± 1.80 | 1.00 ± 2.63 | 1.53 ± 1.51 | 1.01 ± 2.36 | 1.72 ± 1.68 | 0.98 ± 3.18 | 1.87 ± 2.41 | 1.01 ± 2.90 |
| 8-OHdG (μg/g creat.) | 55.9 ± 31.5 | 47.7 ± 1.79 | 58.9 ± 32.9 | 49.3 ± 1.90 | 52.8 ± 36.1 | 45.8 ± 1.67 | 52.3 ± 25.4 | 46.0 ± 1.72 |
Percent change and 95% confidence intervals in biomarker levels associated with each IQR increase in average exposure levels
| PM2.5 | 4.59 | 3.5 (-1.1, 8.4) | 0.4 (-4.3, 5.4) | 3.3 (-8.6, 16.7) | -6.3 (-25.1, 17.3) | 20.6 (2.4, 42.0) |
| EC | 0.51 | -1.2 (-6.8, 4.6) | -1.7 (-7.4, 4.3) | -3.1 (-16.7, 12.8) | -15.0 (-35.6, 12.2) | 17.5 (-4.6, 44.7) |
| OC | 3.62 | -2.2 (-7.8, 3.8) | 2.4 (-3.6, 8.9) | 17.7 (1.2, 36.9) | 4.1 (-21.9, 38.8) | 10.4 (-11.3, 37.4) |
Notes: aLinear mixed effect models for repeated measures using all 4 measurements per participant, with random intercepts for each individual and adjusting for age, BMI, physical activity, hypertension, chronic disease, SHS exposure and in the case of inflammation and endothelial activation markers time varying medication use.
bPollutant models with first and last-day average exposure values (average of available daily exposures over the work-week) as the exposure of interest, with each pollutant modelled separately.
Percent change and 95% confidence intervals in biomarker levels associated with each IQR increase in daily exposure levels
| PM2.5 | 6.11 | -1.1 (-3.7, 1.5) | -1.8 (-4.2, 0.7) | 2.2 (-7.6, 13.0) | -0.2 (-13.1, 14.8) | 8.9 (-6.5, 26.5) |
| EC | 0.56 | 0.1 (-2.5, 2.8) | -0.3 (-2.8, 2.3) | -7.1 (-14.6, 1.0) | -5.3 (-13.7, 4.0) | 4.9 (-9.3, 21.3) |
| OC | 3.97 | -1.1 (-4.4, 2.2) | -1.1 (-4.3, 2.1) | 12.2 (-0.4, 25.8) | 1.2 (-14.7, 20.0) | -3.1 (-18.7, 15.4) |
Notes: aLinear mixed effect models for repeated measures using only the 2 post-shift measurements per participant, with random intercepts for each individual and adjusting for age, BMI, physical activity, hypertension, chronic disease, SHS exposure and in the case of inflammation and endothelial activation markers time varying medication use.
bPollutant models with daily exposure values as the exposure of interest, with each pollutant modelled separately.
Percent change and 95% confidence intervals of IL-6 and 8-OHdG levels associated in multi-exposure models of first and last-day average exposures
| PM2.5 | -0.6 (-13.4, 14.0) | 16.7 (-3.3, 40.9) |
| EC | -4.4 (-18.3, 11.9) | 9.1 (-12.4, 36.0) |
| OC | 18.7 (0.7, 39.8) | 2.2 (-18.5, 28.2) |
Notes: aLinear mixed effect models for repeated measures using all 4 measurements per participant, with random intercepts for each individual and adjusting for age, BMI, physical activity, hypertension, chronic disease, SHS exposure and in the case of IL-6 time varying medication use.
bModels included first and last-day-average values for PM2.5, EC and OC in the same model.
Figure 3Exposure-response penalized spline term graphs. Associations between OC first and last-day average levels and IL-6 (left, effective degrees of freedom (edf) = 1, p = 0.01) and PM2.5 first and last-day average levels and 8-OHdG (right, edf = 1.4, p = 0.02). Models adjusted for age, BMI, physical activity, hypertension, chronic disease, SHS exposure and in the case of IL-6 time varying medication use. (Dashed lines denote 95% CIs).